Griseofulvin CAS 126-07-8: An Antifungal Agent for Dermatophyte Infections

Discover the power of Griseofulvin (CAS 126-07-8), a leading antifungal medication derived from Penicillium griseofulvum, expertly formulated to combat persistent fungal infections of the skin, scalp, and nails. Learn about its mechanism, applications, and advantages.

Get a Quote & Sample

Key Advantages Provided

Targeted Fungal Inhibition

Griseofulvin specifically targets dermatophytes, offering a focused approach to treating infections like ringworm, making it a preferred choice for such conditions.

Systemic Action

Unlike topical treatments, Griseofulvin is taken orally, allowing it to reach the site of infection through the bloodstream and keratin precursor cells, offering comprehensive treatment.

Proven Efficacy

With a long history of use since 1958, Griseofulvin has a well-established track record in successfully treating stubborn fungal infections that do not respond to other therapies.

Key Applications

Skin Infections

Effective in treating fungal infections of the skin, including tinea corporis, tinea cruris, and tinea pedis.

Scalp Infections

Griseofulvin is commonly used for tinea capitis, offering relief from scalp fungal conditions.

Nail Infections

Addresses fungal infections of the fingernails and toenails (onychomycosis) when topical treatments are insufficient.

Pharmaceutical Intermediate

Serves as a crucial intermediate in the synthesis of various pharmaceutical compounds.